Hamburg - Delayed Quote EUR

Vertex Pharmaceuticals Inc (VX1.HM)

Compare
447.95
+25.75
+(6.10%)
As of 5:25:18 PM GMT+1. Market Open.
Loading Chart for VX1.HM
DELL
  • Previous Close 422.20
  • Open 458.10
  • Bid 444.05 x --
  • Ask 445.65 x --
  • Day's Range 444.40 - 458.10
  • 52 Week Range 364.10 - 483.05
  • Volume 11
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: VX1.HM

View More

Performance Overview: VX1.HM

Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

VX1.HM
15.11%
S&P 500
2.25%

1-Year Return

VX1.HM
11.17%
S&P 500
22.64%

3-Year Return

VX1.HM
118.62%
S&P 500
36.29%

5-Year Return

VX1.HM
114.95%
S&P 500
83.94%

Compare To: VX1.HM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VX1.HM

View More

Valuation Measures

Annual
As of 1/30/2025
  • Market Cap

    108.31B

  • Enterprise Value

    103.68B

  • Trailing P/E

    --

  • Forward P/E

    23.92

  • PEG Ratio (5yr expected)

    1.15

  • Price/Sales (ttm)

    10.72

  • Price/Book (mrq)

    7.25

  • Enterprise Value/Revenue

    10.17

  • Enterprise Value/EBITDA

    208.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VX1.HM

View More

Company Insights: VX1.HM

Research Reports: VX1.HM

View More